3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
7
Radiotherapy
6
Radiosurgery
4
pembrolizumab
3
Specimen Handling
3
Paclitaxel
3
Fluorodeoxyglucose F18
3
Carboplatin
3
sargramostim
2
cediranib
2
Thiotepa
2
Radiation
2
Nivolumab
2
Melphalan
2
IFL protocol
2
Granulocyte Colony-Stimulating Factor
2
Genetic Testing
2
Gemcitabine
2
FAPI-46
2
Busulfan
2
130-nm albumin-bound paclitaxel
2
tipifarnib
1
sodium thiosulfate
1
regorafenib
1
paclitaxel-Angiopep-2 conjugate
1
montelukast
1
etoposide phosphate
1
entrectinib
1
entinostat
1
clevudine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Patient-Specific Modeling
×
Gastrointestinal
×
Clear all
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn